<?xml version="1.0" encoding="UTF-8"?>
<ref id="bjh17168-bib-0005">
 <label>5</label>
 <mixed-citation publication-type="miscellaneous" id="bjh17168-cit-0005">
  <collab collab-type="authors">European Society for Medical Oncology – ESMO</collab> . 
  <article-title>ESMO Management and Treatment Adapted Recommendations in the COVID‐19 Era: Multiple Myeloma</article-title>. Available from: 
  <ext-link ext-link-type="uri" xlink:href="https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic/haematological-malignancies-multiple-myeloma-in-the-covid-19-era" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.esmo.org/guidelines/cancer‐patient‐management‐during‐the‐covid‐19‐pandemic/haematological‐malignancies‐multiple‐myeloma‐in‐the‐covid‐19‐era</ext-link> [cited 2020 August 28].
 </mixed-citation>
</ref>
